If you’re wanting to add some blue chip ASX shares to your portfolio, then you’re in luck. The Australian share market is home to a good number of blue chips which I believe could generate strong returns for investors over the next decade.
Three blue chip ASX shares that I would buy are listed below. Here’s why I like them:
Cochlear Limited (ASX: COH)
One of my favourite blue chip ASX shares is Cochlear. I think it could be a fantastic long-term investment due to the ageing populations tailwind. As people age, their hearing tends to fade and will require some form of assistance. Due to the quality of Cochlear’s products and its wide distribution network, I expect the company to benefit greatly from this increasing demand. Another positive is the industry’s high barriers to entry, which I expect to limit competition.
ResMed Inc. (ASX: RMD)
Although ResMed’s shares have been on fire in recent days, I don’t believe it is too late to invest. This is because I think the sleep treatment-focused medical device company has outstanding long term growth potential. This is thanks to its industry-leading position in a market that looks set to grow strongly over the next decade due to the proliferation of obstructive sleep apnoea (OSA). According to a recent presentation, less than 20% of OSA sufferers have been diagnosed or treated.
SEEK Limited (ASX: SEK)
Another of my favourite blue chip ASX shares is SEEK. I think this job listings company would be a great long-term option for investors. Although its profit growth was soft in FY 2019, this was due to its heavy investment in future growth opportunities. In light of this, I feel investors need to focus on its top line performance. Which once again was very strong. SEEK delivered revenue of $1,537.3 million, up 18% on the prior corresponding period. Pleasingly, this strong growth looks set to continue, with management setting itself an aspirational revenue target of $5 billion by FY 2025.
You’re invited! For a limited time, The Motley Fool Australia is giving away an urgent new investment report detailing our 3 TOP BLUE CHIP SHARES to own in 2019.
So if you like trustworthy, stable, high-performing companies that pay fat fully franked dividends – we’ve got you covered!
Stock #1 is a beloved old Australian company turning its attention to high-margin businesses... and rapidly returning cash to shareholders with its hefty dividend...
While Stock #2 is an online powerhouse that’s rapidly gaining market share all around the globe... poised for years (or even decades) of tremendous growth...
Even better, Stock #3 offers a whopping 6.5% grossed-up dividend! Which beats the rates on term deposits right out of the water – and offers the potential for capital gains, too.
You can discover all three shares inside our new report right now. To scoop up your FREE copy, simply click the link below right now. But you will want to hurry – this free report is available for a LIMITED TIME ONLY!
James Mickleboro owns shares of SEEK Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd., ResMed Inc., and SEEK Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.